Corcept Therapeutics | CORT - DÍVIDA





DÍVIDA Alterar Data
Acadia Pharmaceuticals USD 52.19M 2.62M 2025-12
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Ardelyx USD 207.61M 968K 2025-09
Aurora Cannabis CAD 100.34M 1.29M 2025-09
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Canopy Growth CAD 259.33M 68.47M 2025-09
Corcept Therapeutics USD 6.11M 251K 2025-12
Eli Lilly USD 42.5B 3.6M 2025-12
Esperion Therapeutics USD 262.92M 1.76M 2024-09
J&J USD 47.93B 2.14B 2025-12
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
Merck USD 49.34B 7.97B 2025-12
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 47B 11.62B 2026-03
Novartis USD 32.02B 615M 2025-09
Omeros USD 442.16M 199K 2023-09
Pacira USD 367.66M 4.53M 2026-03
Pfizer USD 63.73B 231M 2026-03
Supernus Pharmaceuticals USD 40.98M 1.23M 2025-12
TG Therapeutics USD 253.71M 8.37M 2025-12